World Stem Cell Summit



The UCLA Broad Stem Cell Research Center is a proud sponsor of the World Stem Cell Summit. The Summit is the largest interdisciplinary meeting of stem cell stakeholders, with an overarching purpose of fostering biomedical research and investment targeting cures.

UCLA scientists complete first genome mapping of molecule found in human embryonic stem cells that may regulate gene expression

Stem cell researchers at UCLA have generated the first genome-wide mapping of a DNA modification called 5-hydroxymethylcytosine (5hmC) in embryonic stem cells, and discovered that it is predominantly found in genes that are turned on, or active.       

The finding by researchers with the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA may prove to be important in controlling diseases like cancer, where the regulation of certain genes plays a role in disease development.

UCLA researchers begin first stem cell trials to treat eye diseases

Researchers at the Jules Stein Eye Institute (JSEI) have begun two clinical trials to determine the safety of stem cell therapy and patients’ ability to tolerate it for the treatment of two common, currently untreatable degenerative eye diseases. This FDA-approved study is only the second in the United States to use human embryonic-derived stem cells in patients and the first to address eye diseases.

Scientists with the Broad Stem Cell Research Center at UCLA discover new airway stem cell

Researchers at UCLA have identified a new stem cell that participates in the repair of the large airways of the lungs, which play a vital role in protecting the body from infectious agents and toxins in the environment.

The airways protect the body by producing and clearing mucus. The mucus is largely produced by specialized glands in the airways, and the mechanisms of normal and excessive mucus production are not well understood. However, this newly discovered lung stem cell for the mucus glands will likely yield new insights into this critical process.

Agreement with Roche gives UCLA Stem Cell and Cancer Researchers Early Access to Leading-edge Technologies for the Advancement of Medical Research

An agreement between UCLA and Roche (SIX: RO, ROG; OTCQX: RHHBY) will provide stem cell and cancer researchers with leading-edge technologies that will drive research capabilities and further the understanding of complex disease.

BSCRC and Digestive Diseases Seminar featuring Dr. Dimitrios Iliopoulos


Friday, June 10, 2011
1100 Terasaki Life Sciences Building (TLSB)

Dimitrios Iliopoulos, PhD
Assistant Professor
Department of Cancer Immunology & AIDS
Dana-Farber Cancer Institute

Talk Title: “Identification and Targeting of Molecular Circuits in Colon Cancer Stem Cells”

Light refreshments will be served.

BSCRC and MCDB Seminar featuring Dr. Leanne Jones


Wednesday, June 8, 2011
2320 Life Sciences Building (LSB)

Leanne Jones, Ph.D.
Salk Institute

Talk Title: “Mechanisms Regulating Maintenance of Stem Cells and the Stem Cell Niche”

JCCC Seminar featuring Dr. Tatiana Segura


Seminar featuring Dr. Ben Raphael


Tuesday, May 24, 2011
3400 Boelter

Ben Raphael, Ph.D.
Assistant Professor
Computer Science Department
Brown University

Title: Algorithms for Cancer Genomics

Division of Cardiology Seminar featuring Dr. Reza Ardehali


Monday, June 6, 2011
9:00AM - 10:00AM
1441 MRL

Reza Ardehali, M.D., Ph.D.
Fellow in Cardiovascular Medicine
Stanford University Medical Center

Talk Title: "Prospective Identification of Cardiovascular Progenitors From Human Embryonic Stem Cells"